MetaCap

Who Owns Tenaya Therapeutics Stock?

NASDAQ: TNYAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.2866-0.0119 (-3.99%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
48.86%
Institutional holders
125
  • Institutions 48.9%
  • Insiders 0.5%
  • Public and other 50.7%

Who owns Tenaya Therapeutics stock?

Institutional investors own about 48.9% of Tenaya Therapeutics's shares, spread across 125 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.48% of TNYA.

The largest institutional holders are Vanguard Capital Management LLC (3.17%), Millennium Management Llc (2.87%) and Citadel Advisors Llc (2.04%). Together, the top 10 institutions control 18.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TNYA positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of TNYA

Tenaya Therapeutics top institutional holders
InstitutionShares% HeldChange
Vanguard Capital Management LLC7.10M3.17%-16.3%
Millennium Management Llc6.43M2.87%+17.8%
Citadel Advisors Llc4.57M2.04%+8.7%
Renaissance Technologies, LLC4.28M1.91%+15.3%
Blackrock Inc.4.01M1.79%+8.2%
Empery Asset Management, LP3.86M1.72%-9.9%
Marshall Wace LLP3.50M1.56%+29.5%
GSA Capital Partners LLP2.67M1.19%+148.8%
Burkehill Global Management, LP 2.00M0.89%0.0%
Geode Capital Management, LLC1.83M0.82%+17.6%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of TNYA

Tenaya Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund5.14M2.29%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.77M0.79%
iShares Trust-iShares Biotechnology ETF1.57M0.70%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund550.29K0.25%
Fidelity Concord Street Trust-Fidelity Total Market Index Fund302.89K0.14%
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund231.32K0.10%
Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF221.85K0.10%
GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund161.86K0.07%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund131.80K0.06%
Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF128.68K0.06%

Frequently asked questions

Who is the largest shareholder of Tenaya Therapeutics?

Vanguard Capital Management LLC is the largest institutional shareholder of TNYA, owning 3.17% of shares outstanding (7.10M shares) as of its latest 13F filing.

What percentage of Tenaya Therapeutics is owned by institutions?

Institutions own about 48.9% of TNYA shares and 49.1% of the public float.

How much of Tenaya Therapeutics do insiders own?

Insiders, such as officers and directors, own about 0.48% of TNYA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related